Skip to main content

Breast Cancer

Ausgabe 4/2017

Inhalt (21 Artikel)

Special Feature

Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements

Takashi Ishikawa, Hiroshi Kaise, Kimito Yamada, Mari Hosonaga, Takashi Chishima, Kazutaka Narui, Akimitsu Yamada, Sadatoshi Sugae, Yasushi Ichikawa, Mitsuyoshi Ota, Miyako Nozaki, Ryuji Mikami, Koichi Tokuuye

Special Feature

Post-mastectomy radiation therapy in breast cancer with 1–3 involved lymph nodes: the Pros

Keiichiro Tada, Kotoe Nishioka, Yasuko Kikuchi, Takayoshi Niwa, Yasuyuki Seto

Special Feature

Postmastectomy radiation therapy and breast reconstruction with autologous tissue

Yasunobu Terao, Koichiro Taniguchi, Miwako Fujii, So Moriyama

Review Article

The role of miR-130a in cancer

He-da Zhang, Lin-hong Jiang, Da-wei Sun, Jian Li, Zhen-ling Ji

Original Article

Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes

Kaori Tane, Chiyomi Egawa, Shintaro Takao, Kazuhiko Yamagami, Masaru Miyashita, Masashi Baba, Shigetoshi Ichii, Muneharu Konishi, Yuichiro Kikawa, Junya Minohata, Toshitaka Okuno, Keisuke Miyauchi, Kazuyuki Wakita, Hirofumi Suwa, Takashi Hashimoto, Masayuki Nishino, Takashi Matsumoto, Toshiharu Hidaka, Yutaka Konishi, Yoko Sakoda, Akihiro Miya, Masahiro Kishimoto, Hidefumi Nishikawa, Seishi Kono, Ikuo Kokufu, Isao Sakita, Koushiro Kitatsuji, Koushi Oh, Kouhei Akazawa, Yasuo Miyoshi

Original Article

Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer

Teng Li, Yun Liu, Haifeng Xiao, Guanghui Xu

Original Article

Effect of the childhood trauma on the adjustment to cancer in the patients with breast cancer

Hulya Guveli, Murat Emin Guveli, Fatma Sen, Serap Oflaz, Necla Gurdal, Makbule Tambas, Seden Kucucuk, Adnan Aydıner, Mine Ozkan

Original Article

NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer

Kobra Velaei, Nasser Samadi, Sina Soltani, Balal Barazvan, Jafar Soleimani Rad

Original Article

TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population

Amir Hossain, Gazi Md. Monjur Murshid, Md. Nazmul Hasan Zilani, Fahrima Islam, Razia Sultana, Tamanna Sultana, Md. Golam Hossain, Md. Mustafizur Rahman

Original Article

Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk

Madoka Iwase, Hiroko Tsunoda, Kanako Nakayama, Emiko Morishita, Naoki Hayashi, Koyu Suzuki, Hideko Yamauchi

Original Article

Accuracy assessment methods of tissue marker clip placement after 11-gauge vacuum-assisted stereotactic breast biopsy: comparison of measurements using direct and conventional methods

Hidetoshi Yatake, Yuka Sawai, Toshio Nishi, Yoshiaki Nakano, Ayaka Nishimae, Toshizo Katsuda, Koichi Yabunaka, Yoshihiro Takeda, Hideo Inaji

Open Access Original Article

Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis

Seiya Ota, Ryo Inoue, Takashi Shiozaki, Yuji Yamamoto, Naoki Hashimoto, On Takeda, Kei Yoshikawa, Junji Ito, Yasuyuki Ishibashi

Open Access Original Article

Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial

Manabu Futamura, Yasuko Nagao, Kazuhiro Ishihara, Makoto Takeuchi, Takumi Nakada, Yoshihiro Kawaguchi, Masayoshi Asano, Iwao Kumazawa, Takashi Shiroko, Kasumi Morimitsu, Ryutaro Mori, Masahito Nawa, Toshio Shimokawa, Kazuhiro Yoshida

Original Article

Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study

Giulia Galli, Anna Tessari, Luca Porcu, Giacomo Bregni, Biagio Paolini, Maria Luisa Carcangiu, Massimiliano Gennaro, Maria Carmen De Santis, Laura Lozza, Filippo de Braud, Serena Di Cosimo

Erratum

Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Norikazu Masuda, Touko Inao, Mitsuchika Hosoda, Naoko Ishida, Tomofumi Osako, Masato Takahashi, Yumi Endo, Yuichiro Miyoshi, Hiroyuki Yasojima, Nobumoto Tomioka, Hiroko Yamashita

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.